STAT3 inhibitor curcumin

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 11 X posts from 7 X users, with an upper bound of 167,579 followers.

RT @a_m_molenda: Dostarlimab PD-1–blocking monoclonal antibody 1. https://t.co/0jjq403jr8 2. https://t.co/rvVAP9CEtj 3. Approved PD-1/PD…

Dostarlimab PD-1–blocking monoclonal antibody 1. https://t.co/0jjq403jr8 2. https://t.co/rvVAP9CEtj 3. Approved PD-1/PD-L1 inhibitors https://t.co/w0Tjwa3p41 4. Enhanced anti-tumor effects of the PD-1/PD-L1 blockade by curcumin https://t.co/tHn8oNqXRp

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.